January 4 (SeeNews) - Bulgarian medical consumables traded Bioiasis said that Cyprus-based Schutt-Andersen Holding has launched a buyout bid priced at 1.15 levs ($0.67/0.59 euro) per share for the remaining 3.05% in the company it does not currently own.
Schutt-Andersen Holding's offer targets 36,603 shares in the company, Bioiasis said in a statement earlier this week.
You can subscribe to our M&A newsletter here
Bulgaria's Financial Supervision Commission has not yet allowed publication of the offer.
Schutt-Andersen Holding does not intend to delist the company from the Bulgarian Stock Exchange following completion of the buyout bid.
Bioiasis shares last traded on the Bulgarian Stock Exchange in 2015, at a price of 16.08 levs apiece. The company was established in 2005 and obtained license to trade with medical devices from the Bulgarian Drug Agency, before going public in 2008.
(1 euro = 1.95583 levs)